To avoid the high costs and long lead times needed for target discovery, Galaxy selects a limited number of targets that have already been described in the scientific literature but have not been exploited for various reasons, such as difficulty in developing suitable mAbs.Stay focused on research by outlicensing product candidates at the preclinical stage to larger pharmaceutical or biotechnology companies.

Research Grants 6 show all


$655.5K
2006

$122.2K
2009

$117.6K
2010

$443.2K
2011

$504K
2012

Publications 10 show all

  • 4
    Xanthomonas campestris/metabolism
  • 3
    Polysaccharides, Bacterial/metabolism
  • 2
    Antibodies, Monoclonal/therapeutic use
  • 2
    Glycerol/metabolism
  • 2
    Industrial Microbiology/methods
  • 1
    Antibodies, Monoclonal/pharmacology
  • 1
    Biomarkers, Tumor/metabolism
  • 1
    Brain Neoplasms/prevention & control
  • 1
    Carcinoma, Hepatocellular/drug therapy
  • 1
    Carcinoma/therapy

Patents 153show all

  • 16
    A61K - Preparations for medical, dental, or toilet purposes
  • 16
    C07K - Peptides
  • 1
    G01N - Investigating or analysing materials by determining their chemical or physical properties

Contact Information

1230 Bordeaux Dr
Sunnyvale, CA 94089
United States

Overview

Total FundingEmployeesLast Funding DateStatus
unknownOperating